Skip to main content
. 2022 Jan 6;12:779531. doi: 10.3389/fmicb.2021.779531

TABLE 2.

MIC distribution of sitafloxacin for 194 clinical, M. abscessus isolates.

M. abscessus No. of isolates Number of isolates exhibiting the MIC (mg/L) of sitafloxacin indicated
MIC50 (mg/L)a MIC90 (mg/L)a
0.25 0.5 1 2 4 8
subsp. abscessusb 148 11 55 63 15 3 1 1 2
subsp. Massiliense 46 1 10 18 16 1 0 1 2

aMIC50 and MIC90, the sitafloxacin concentration at which 50 and 90% of the clinical isolates tested, respectively, were inhibited. bM. abscessus subsp. abscessus was significantly more sensitive than subsp. massiliense to sitafloxacin treatment, P < 0.001.